Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population
2012
Hepatocellular carcinoma
2003 Standout
Vaccination of immunocompromised patients
2012
Surveillance for Early Diagnosis of Hepatocellular Carcinoma: Is It Effective in Intermediate/Advanced Cirrhosis?
2007
Hepatocellular carcinoma
2016 Standout
Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates
2001
Hepatocellular carcinoma
2018 Standout
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis
2008
Vaccination in Solid Organ Transplantation
2013
Resection of Hepatocellular Carcinoma Without Preoperative Tumor Biopsy
2001
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival
2010
Hepatitis B virus prevention strategies for antibody to hepatitis B core antigen–positive liver donation: A survey of North American, European, and Asian-Pacific transplant programs
2009
Is tumor biopsy necessary?
2011
Hepatocellular carcinoma
2012 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
Efficacy of repeated high‐dose hepatitis B vaccine (80 μg) in patients with chronic liver disease
2005
Global cancer transitions according to the Human Development Index (2008–2030): a population-based study
2012 Standout
Use of Surveillance for Hepatocellular Carcinoma Among Patients With Cirrhosis in the United States
2010
Screening for Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis: A Cost-Utility Analysis
2003
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Management of Hepatocellular Carcinoma: An Update Δσ
2011 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Global cancer statistics
2011 Standout
Preoperative Predictors of Survival After Resection of Small Hepatocellular Carcinomas
2002
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
2012 Standout
Screening for hepatocellular carcinoma in cirrhosis
2003
Accuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review. CME
2006
Guidelines for Vaccination of Solid Organ Transplant Candidates and Recipients
2009
Immunizations in Chronic Liver Disease: What Should be Done and What is the Evidence
2012
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
2018
Alkaloids: An overview of their antibacterial, antibiotic-enhancing and antivirulence activities
2014 Standout
Global Patterns of Cancer Incidence and Mortality Rates and Trends
2010 Standout
Successful Immune Response to a Recombinant Hepatitis B Vaccine in Children After Liver Transplantation
2001
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
2006 Standout
Hepatocellular Carcinoma
2011 Standout
Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma
2009
Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus–related cirrhosis
2005
Utilization of Screening for Hepatocellular Carcinoma in the United States
2007
Hepatocellular Carcinoma
2019 Standout
Utilization of Surveillance for Hepatocellular Carcinoma Among Hepatitis C Virus–Infected Veterans in the United States
2011
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Screening for liver cancer: results of a randomised controlled trial in Qidong, China
2003
Response to hepatitis B vaccination in patients with liver cirrhosis
2017
Reappraisal of serum alpha‐foetoprotein as a surveillance test for hepatocellular carcinoma during entecavir treatment
2014
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.
2008
Loop diuretics: from the Na-K-2Cl transporter to clinical use
2003
Test Characteristics of α-Fetoprotein for Detecting Hepatocellular Carcinoma in Patients with Hepatitis C
2003
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma
2015
Works of John C. Horlander being referenced
Effects of Albumin/Furosemide Mixtures on Responses to Furosemide in Hypoalbuminemic Patients
2001
Screening for Hepatocellular Carcinoma in Patients With Advanced Cirrhosis
1999
Vaccination against Hepatitis B in Patients with Chronic Liver Disease Awaiting Liver Transplantation
1999
Vaccination against Hepatitis B in Patients with Chronic Liver Disease Awaiting Liver Transplantation
1999